Business Wire - ZIOPHARM Presents Preliminary ZIO-201 Clinical Results at ASCO
Posted on Monday, June 05 @ 07:00:00 CDT by admin
June 5, 2006 -- ATLANTA -- ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today preliminary data from a phase I study of ZIO-201 (isophosphoramide mustard-lysine) ...
Click Here to read the entire article...
|
| |
|